Hypertension Drug Market

Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys.

Hypertension Drug Market contains market size and forecasts of Hypertension Drug in global, including the following market information:

• Global Hypertension Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Hypertension Drug Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Hypertension Drug companies in 2021 (%)

The global Hypertension Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Calcium Channel Blockers Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hypertension Drug include Lupin Limited, Novartis AG, Daiichi - Sankyo, Pfizer Inc, Ranbaxy Laboratories Limited, Sanofi S.A, AstraZeneca Plc, Johnson & Johnson Ltd and Boehringer Ingelheim and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Hypertension Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hypertension Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hypertension Drug Market Segment Percentages, by Type, 2021 (%)

• Calcium Channel Blockers
• Diuretics
• Beta Blockers Vasodilators
• Angiotensin Converting Enzyme Inhibitors
• Alpha Blockers
• Angiotensin Receptor Blockers
• Renin Inhibitors

Global Hypertension Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hypertension Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Private Clinic
• Others

Global Hypertension Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Hypertension Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Hypertension Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Hypertension Drug revenues share in global market, 2021 (%)
• Key companies Hypertension Drug sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Hypertension Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Lupin Limited
• Novartis AG
• Daiichi - Sankyo
• Pfizer Inc
• Ranbaxy Laboratories Limited
• Sanofi S.A
• AstraZeneca Plc
• Johnson & Johnson Ltd
• Boehringer Ingelheim
• Merck & Co.